Evidence map›Paper›PMID 28357131›Full record

ArticlePilot and feasibility studies2017

Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.

Daniel Hind, James Parkin, Victoria Whitworth, Saleema Rex, Tracey Young, Lisa Hampson, Jennie Sheehan, Chin Maguire, Hannah Cantrill, Elaine Scott and 12 more

Open access · goldAbstract read
In one paragraph

Article in Pilot and feasibility studies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

Daniel HindSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
James ParkinSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
Victoria WhitworthSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
Saleema RexSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
Tracey YoungSchool of Health and Related Research, Sheffield, UK.
Lisa HampsonDepartment of Mathematics and Statistics, University of Lancaster, Lancaster, UK.
Jennie SheehanEvelina London Childrens Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Chin MaguireSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
Hannah CantrillSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
Elaine ScottSchool of Health and Related Research, Sheffield, UK.
Heather EppsAquaepps, Dorking, Surrey UK.
Marion MainDubowitz Neuromuscular Centre (DNC), The UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Michelle GearyChildren's Therapy Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Heather McMurchiePaediatric Physiotherapy, Heart of England NHS Foundation Trust, Birmingham, UK.
Lindsey PallantRegional Paediatric Neuromuscular Team, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Daniel WoodsPaediatric Neurology, Sheffield Children's Hospital, Sheffield, UK.
Jennifer FreemanLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Ellen LeeSheffield Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.
Michelle EagleNewcastle Muscle Centre, Newcastle University, Newcastle, UK.
Tracey WillisThe Oswestry Inherited Neuromuscular Service, The Robert Jones and Agnes Hunt, Orthopaedic Hospital NHS Foundation Trust, Oswestry, UK.
Francesco MuntoniDubowitz Neuromuscular Centre (DNC), The UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Peter BaxterPaediatric Neurology, Sheffield Children's Hospital, Sheffield, UK.
University of Sheffield · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBSheffield Children's Hospital · GBEvelina London Children's Healthcare · GBHeart of England NHS Foundation Trust · GBLancaster University · GBLeeds Teaching Hospitals NHS Trust · GBNewcastle University · GBRobert Jones and Agnes Hunt Orthopaedic Hospital · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Leeds · GB

Funding

Department of Health 12/144/04
6 · The paper itself

Abstract

backgroundStandard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in a parallel-group pilot randomised trial (primary objective), also assessing how intervention and trial procedures work.

methodsAmbulant boys with DMD aged 7-16 years established on steroids, with North Star Ambulatory Assessment (NSAA) score ≥8, who were able to complete a 10-m walk test without aids or assistance, were randomly allocated (1:1) to 6 months of either optimised land-based exercises 4 to 6 days/week, defined by local community physiotherapists, or the same 4 days/week plus AT 2 days/week. Those unable to commit to a programme, with >20% variation between NSAA scores 4 weeks apart, or contraindications to AT were excluded. The main outcome measures included feasibility of recruiting 40 participants in 6 months from six UK centres, clinical outcomes including NSAA, independent assessment of treatment optimisation, participant/therapist views on acceptability of intervention and research protocols, value of information (VoI) analysis and cost-impact analysis.

resultsOver 6 months, 348 boys were screened: most lived too far from centres or were enrolled in other trials; 12 (30% of the targets) were randomised to AT (

conclusionsNeither a UK-based RCT of AT nor a twice weekly AT therapy delivered at tertiary centres is feasible. Our study will help in the optimisation of AT service provision and the design of future research.

trial registrationISRCTN41002956.

Indexed as

Aquatic therapyDuchenne muscular dystrophyFeasibility studyHydrotherapyPhysical therapyPilot study

Identifiers

PMID28357131
PMCPMC5367005
OpenAlexW2602350000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.